Health And Wellness Articles At Vitanet®, LLC.

Log In  |   Log Out  |   Cart   |   My Account  
Free shipping on orders over $100!!*
   Serving Customers Online Over 13 Years!








BackRefreshSearch
New antibiotics expected for resistant pneumonia bugs
old message New antibiotics expected for resistant pneumonia bugs VitaNet ® Staff 10/10/05


PreviousNextListen To An Article On New antibiotics expected for resistant pneumonia bugs

Date: October 10, 2005 11:52 AM
Author: VitaNet ® Staff (support@vitanet.net)
Subject: New antibiotics expected for resistant pneumonia bugs

New antibiotics expected for resistant pneumonia bugs

Scientists recently announced the expected arrival of a new family of bacteria-killers on the horizon for pneumonia and other diseases. These new antibiotics should offer an alternative to standard antibiotics, many of which have lost their punch against increasingly resistant germs.

The standard treatment today for many bacterial infections that cause respiratory diseases are medicines called macrolides. These include well-known antiobiotics like penicillin and erythromycin. However, certain bacteria strains are growing resistant to them, as well as to the primary back-up medicines, known as quinolones.

The pharmaceutical industry's response to this problem is ketolides. Ketolides are derived from macrolides, but since they have a different chemical composition, they will kill bacteria that are resistant to macrolides. Researchers recently presented reports on two varieties of ketolides at an infectious diseases meeting sponsored by the American Society for Microbiology. Aventis Pharmaceuticals recently filed with the U.S. Food and Drug Administration to gain permission to sell a new ketolide antibiotic, Ketek, or telithromycin. A similar drug made by Abbott Pharmaceuticals, code named ABT-773, is also in the early stages of human testing.

Researchers presented new Ketek studies involving 2,500 patients. These reports intended to show how the once-a-day Ketek is equally effective as other standard antibiotics in treating many bacterial diseases, including pneumonia, bronchitis, sinus infections and sore throats. Scientist also say since the Ketek treatment lasts just five days, which is shorter than most antibiotic treatments, bacteria may be less likely to grow resistant to the new drug.



--
Discount vitamins at Vitanet ®











Source Naturals - Our Prices are 49% OFF MSRP at VitanetOnline.com, VitaNet ®, LLC


Support -- Copyright © 1995-2008. VitaNet ®, LLC All rights reserved.


----- Feel Free to Link to our pages -----

<A href="http://vitanetonline.com/forums/1/Thread/578" targe=_blank>New antibiotics expected for resistant pneumonia bugs</A>

----- Feel Free to Link to our pages -----

New antibiotics expected for resistant pneumonia bugs
,

Natural Products Association Paypal: Solution Graphics Official PayPal Seal Official BBB Seal

Disclaimer: All material provided in the VitaNet ®, LLC. website is provided for educational purposes only. Consult your physician regarding the applicability of any information provided in the VitaNet ®, LLC. website to your symptoms or medical condition. *These statements have not been evaluated by the Food and Drug Administration. These web pages are not intended to diagnose, treat, cure, or prevent any disease.